Dispelling urban myths about default uncertainty factors in chemical risk assessment - Sufficient protection against mixture effects?

Environmental Health: A Global Access Science Source

Volumn 12, Issue 1, 2013, Pages

  Martin, Olwenn V ^a   Martin, Scholze ^a   Andreas, Kortenkamp ^a  

^a BRUNEL UNIVERSITY   (United Kingdom)

Author keywords

Acceptable daily intake; Extrapolation; Hazard assessment; Mixture; Risk assessment

Indexed keywords

CHEMICAL AGENT; POLLUTANT;

DATA SET; HAZARD ASSESSMENT; HEALTH RISK; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY ANALYSIS; UNCERTAINTY ANALYSIS;

ARTICLE; CHEMICAL ANALYSIS; ENVIRONMENTAL EXPOSURE; EVOLUTION; EXPERIMENTAL ANIMAL; GOVERNMENT REGULATION; HAZARD ASSESSMENT; HUMAN; LITERATURE; NONHUMAN; POPULATION; PRIORITY JOURNAL; RISK ASSESSMENT; SAFETY; TOXICOKINETICS; URBAN POPULATION; ANIMAL; DRUG INTERACTION; POLLUTANT; SPECIES DIFFERENCE; UNCERTAINTY;

ANIMALS; DRUG INTERACTIONS; ENVIRONMENTAL POLLUTANTS; HUMANS; RISK ASSESSMENT; SPECIES SPECIFICITY; UNCERTAINTY;

EID: 84880145872     PISSN: None     EISSN: 1476069X     Source Type: Journal    
DOI: 10.1186/1476-069X-12-53     Document Type: Article

References (111)

1. ECETOC, Derivation of assessment factors for human health risk assessment TR 86 Brussels: European Centre for Ecotoxicology and Toxicology of Chemicals 2003
2. ECETOC, Guidance on assessment factors to derive a DNEL TR No 110 Brussels: European Centre for Ecotoxicology and Toxicology of Chemicals 2010
3. Kalberlah F, Schneider K, Quantification of Extrapolation Factors No 1116 06 113 Dortmund/Berlin: Bundesanstalt Fur Arbeitsschutz und Arbeitsmedizin 1998
4. KEMI, Proposals for the use of assessment (uncertainty) factors-application to risk assessment for plant protection products, industrial chemicals and biocidal products within the European union No 1/03 Stockholm: The Swedish National Chemicals Inspectorate 2003 http://www.kemi.se/Documents/ Publikationer/Trycksaker/Rapporter/Rapport1-03.pdf, last accessed 23/04/2013
5. Vermeire TG, Pieters M, Rennen M, Bos PMJ, Probabilistic assessment factors for human health risk assessment: a practical guide. RIVM report 601 516 005 Bilthoven: RIVM-TNO 2001 http://www.rivm.nl/dsresource?objectid=rivmp: 15789&type=org&disposition=inline&ns-nc=1, last accessed 23/04/2013
6. SCHER/SCENIHR/SCCS, Opinion on the toxicity and assessment of chemical mixtures Brussels: European Commission 2012 http://ec.europa.eu/health/ scientific-committees/environmental-risks/docs/scher-o-155.pdf, last accessed 23/04/2013
7. European Commission, Communication from the commission to the council-the combination effects of chemicals Brussels: European Commission COM(2012) 252 final. 2012 http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=COM:2012:0252: FIN:EN:PDF, last accessed 23/04/2013
8. The toxicity of poisons applied jointly. Bliss CI, Ann Appl Biol 1939 26 585 615 10.1111/j.1744-7348.1939.tb06990.x
9. Joint algal toxicity of 16 dissimilarly acting chemicals is predictable by the concept of independent action. Faust M, Altenburger R, Backhaus T, Blanck H, Boedecker W, Grammatica P, Hamer V, Scholze M, Vighi M, Grimme LH, Aquat Toxicol 2003 63 43 63 10.1016/S0166-445X(02)00133-9 12615420 (Pubitemid 36287134)
10. Predictability of the toxicity of a multiple mixture of dissimilarly acting chemicals to vibrio fischeri. Backhaus T, Altenburger R, Boedecker W, Faust M, Scholze M, Grimme LH, Environ Toxicol Chem 2000 19 2348 2356
11. Kortenkamp A, Evans R, Faust M, Kalberlah F, Scholze M, Schuhmacher-Wolz U, Investigation of the state of the science on combined actions of chemicals in food through dissimilar modes of action and proposal for science-based approach for performing related cumulative risk assessment Parma: European Food Standard Agency 2012
12. Kortenkamp A, Backhaus T, Faust M, State of the Art report on mixture toxicity Brussels: European Commission 2009
13. The concept of the acceptable daily intake-an historical review. Truhaut R, Food Addit Contam 1991 8 151 162 10.1080/02652039109373965 1868927
14. JEFCA, Principles governing consumer safety in relation to pesticide residues Geneva: World Health Organization WHO technical report, Volume 240. 1962 http://apps.who.int/iris/bitstream/10665/40536/1/WHO-TRS-240.pdf, last accessed 23/04/2013
15. European Community, REGULATION (EC) NO 396/2005 OF THE EUROPEAN PARLIAMENT AND OF THE COUNCIL of 23 February 2005 on maximum residue levels of pesticides in or on food and feed of plant and animal origin and amending council directive 91/414/EEC Brussels: European Community 2005 EC No 396/2005
16. National Research Council, Science and decisions: advancing risk assessment Washington DC: National Academy Press Committee on improving risk analysis approaches used by the U.S.EPA. 2008
17. IPCS, Principles for the toxicological assessment of pesticide residues in food Geneva: World Health Organization Environmental health criteria 104. 1990 http://www.inchem.org/documents/ehc/ehc/ehc104.htm, last accessed 23/04/2013
18. IPCS, Principles and methods for the risk assessment of chemicals in food Geneva: World Health Organization Environmental health criteria 240. 2009 http://www.who.int/foodsafety/chem/principles/en/index1.html, last accessed 23/04/2013
19. A straw man proposal for a quantitative definition of the RfD. Hattis D, Baird S, Goble R, Drug Chem Toxicol 2002 25 403 436 10.1081/DCT-120014793 12378950
20. Thresholds in toxicology and risk assessment. Slob W, Int J Toxicol 1999 18 259 268 10.1080/109158199225413 (Pubitemid 29409290)
21. Statistical power considerations show the endocrine disruptor Low-dose issue in a New light. Scholze M, Kortenkamp A, Environ Heal Perspect 2007 115 84 90 10.1289/ehp.9364
22. IPCS, Principles for the assessment of risks to human health from exposure to chemicals Geneva: World Health Organization Environmental health criteria 210. 1999 http://www.inchem.org/documents/ehc/ehc/ehc210.htm, last accessed 2e3/04/2013
23. Safety factors and their application in the toxicological evaluation. Vettorazzi G, Proceedings of the International Colloquium on the evaluation of Toxicological Data for the protection of Public Health: December 1976; Luxembourg Oxford: Pergamon Press, Hunter WJ, Smeets JGPM, 1977 207 223
24. A new method for determining allowable daily intakes. Crump KS, Fundam Appl Toxicol 1984 4 854 871 10.1016/0272-0590(84)90107-6 6510615 (Pubitemid 15184906)
25. Past and future Use of default assumptions and uncertainty factors: default assumptions, misunderstandings, and New concepts. Dourson ML, Parker A, Human Ecol Risk Assess 2007 13 82 87 10.1080/10807030601105480 (Pubitemid 46277823)
26. What role for biologically based dose-response models in estimating Low-dose risk? Crump KS, Chen C, Chiu WA, Louis TA, Portier CJ, Subramaniam RP, White PD, Environ Heal Perspect 2010 118 585 588 10.1289/ehp.0901249
27. State-of-the-science workshop report: issues and approaches in Low-dose: response extrapolation for environmental health risk assessment. White RH, Cote I, Zeise L, Fox M, Dominici F, Burke TA, White PD, Hattis DB, Samet JM, Environ Heal Perspect 2009 117 283 287
28. 100-Fold margin of safety. Lehman AJ, Fitzhugh OG, Q Bull-Assoc Food Drug Officials 1954 18 33 35
29. JECFA, Procedures for the testing of intentional food additives to establish their safety for use-second report of the joint FAO/WHO expert committee on food additives Geneva: World Health Organization Technical report series, Volume 144. 1958 [ http://apps.who.int/iris/bitstream/10665/40403/1/WHO- TRS-144.pdf, last accessed 23/04/2013]
30. The acceptable daily intake of food additives. Bigwood EJ, Crit Rev Toxicol 1973 2 41 93
31. Regulatory history and experimental support of uncertainty (safety) factors. Dourson ML, Stara JF, Regul Toxicol Pharmacol 1983 3 224 238 10.1016/0273-2300(83)90030-2 6356243 (Pubitemid 14229334)
32. JEFCA, Toxicological evaluations of certain food additives with a review of general principles and of specifications-seventeenth report of the joint FAO/WHO expert committee on food additives Geneva: World Health Organisation WHO technical report series, Volume 539. 1974 http://apps.who.int/iris/bitstream/ 10665/41072/1/WHO-TRS-539.pdf, last accessed 23/04/2013
33. IPCS, Principles for the safety assessment of food additives and contaminants in food Geneva: World Health Organization Environmental health criteria, Volume 70. 1987 http://www.inchem.org/documents/ehc/ehc/ehc70.htm, last accessed 23/04/2013
34. Workshop on the scientific evaluation of the safety factor for the acceptable daily intake (Adi)-editorial summary. Kroes R, Munro I, Poulsen E, Food Addit Contam 1993 10 269 273 10.1080/02652039309374151 8359311 (Pubitemid 23218111)
35. A new approach to deriving community exposure guidelines from «no-observed-adverse-effect levels» Lewis SC, Lynch JR, Nikiforov AI, Regul Toxicol Pharmacol 1990 11 314 330 10.1016/0273-2300(90)90030-F 2196639 (Pubitemid 20325472)
36. Data-derived safety factors for the evaluation of food-additives and environmental contaminants. Renwick AG, Food Addit Contam 1993 10 275 305 10.1080/02652039309374152 8359312 (Pubitemid 23218112)
37. Safety factors and establishment of acceptable daily intakes. Renwick AG, Food Addit Contam 1991 8 135 150 10.1080/02652039109373964 1868926
38. Human variability in susceptibility to toxic-chemicals-a preliminary-analysis of pharmacokinetic data from normal volunteers. Hattis D, Erdreich L, Ballew M, Risk Analysis 1987 7 415 426 10.1111/j.1539-6924.1987. tb00479.x 3444929 (Pubitemid 18033523)
39. IPCS, Assessing human health risks of chemicals: derivation of guidance values for health-based exposure limits Geneva: World Health Organization Environmental health criteria, Volume 170. 1994 http://www.inchem.org/documents/ ehc/ehc/ehc170.htm, last accessed 23/04/2013
40. Guidelines for application of chemical-specific adjustment factors in dose/concentration-response assessment. Meek ME, Renwick A, Ohanian E, Dourson M, Lake B, Naumann BD, Vu V, Toxicology 2002 181 115 120 12505295 (Pubitemid 36015683)
41. Use of toxicokinetic and toxicodynamic data to reduce uncertainties when setting occupational exposure limits for pharmaceuticals. Naumann BD, Weideman PA, Dixit R, Grossman SJ, Shen CF, Sargent EV, Human Ecol Risk Assess 1997 3 555 565 10.1080/10807039709383711 (Pubitemid 127717229)
42. Case studies of categorical data-derived adjustment factors. Naumann BD, Silverman KC, Dixit R, Faria EC, Sargent EV, Human Ecol Risk Assess 2001 7 61 105 10.1080/20018091094213 (Pubitemid 33817303)
43. Establishing data-derived adjustment factors from published pharmaceutical clinical trial data. Silverman KC, Nanmann BD, Holder DJ, Dixit R, Faria EC, Sargent EV, Gallo MA, Human Ecol Risk Assess 1999 5 1059 1089 10.1080/10807039991289347 (Pubitemid 129725210)
44. Pathway-related factors: the potential for human data to improve the scientific basis of risk assessment. Renwick AG, Dorne JLCM, Walton K, Human Ecol Risk Assess 2001 7 165 180 10.1080/20018091094286
45. ECHA, Guidance on information requirements and chemical safety assessment-chapter R.8: characterisation of dose [concentration]-response for human health Helsinki: European Chemicals Agency 2008 http://echa.europa.eu/ documents/10162/13632/information-requirements-r8-en.pdf, last accessed 23/04/2013
46. USEPA, Reference dose (RfD): description and use in health risk assessments: U.S.Environmental Protection Agency Background document 1A. 1993 [ http://www.epa.gov/iris/rfd.htm, last accessed 23/04/2013]
47. Danish EPA, Methods for the derivation of health based limit values for chemical substances in soil, air, and drinking water Copenhagen: Danish EPA Guidance from the Danish EPA no5/2006. 2006
48. Time extrapolation and interspecies extrapolation for locally acting substances in case of limited toxicological data. Kalberlah F, Fost U, Schneider K, Ann Occup Hyg 2002 46 175 185 10.1093/annhyg/mef014 12074027 (Pubitemid 36554340)
49. Assessment factors for human health risk assessment: a discussion paper. Vermeire TG, Stevenson H, Pieters MN, Rennen M, Slob W, Hakkert BC, Crit Rev Toxicol 1999 29 439 490 10.1080/10408449991349249 10521133 (Pubitemid 29477890)
50. Are conundrums with uncertainty factors an obstacle to developing probabilistic interpretations of noncancer risks from chemicals? Goble R, Hattis D, Risk Analysis 2010 30 340 345 10.1111/j.1539-6924.2010.01364.x 20487391
51. Biological basis for extrapolation across mammalian-species. Davidson IWF, Parker JC, Beliles RP, Regul Toxicol Pharmacol 1986 6 211 237 10.1016/0273-2300(86)90014-0 3775081
52. Interspecies extrapolation-a reexamination of acute toxicity data. Watanabe K, Bois FY, Zeise L, Risk Analysis 1992 12 301 310 10.1111/j.1539-6924. 1992.tb00677.x 1502377
53. Evolutionary biology, animal behavior, 4§ssup§th§ esup§-dimensional space, and the raison D'Être of drug-metabolism and pharmacokinetics. Boxenbaum H, Drug Metabolism Rev 1983 14 1057 1097 10.3109/03602538308991421 (Pubitemid 14229914)
54. Does the animal-to-human uncertainty factor incorporate interspecies differences in surface area? Calabrese EJ, Beck BD, Chappell WR, Regul Toxicol Pharmacol 1992 15 172 179 1626068
55. Polychlorinated-biphenyls and the developing nervous-system-cross-species comparisons. Tilson HA, Jacobson JL, Rogan WJ, Neurotoxicology and Teratology 1990 12 239 248 10.1016/0892-0362(90)90095-T 2115098 (Pubitemid 20344188)
56. Quantitative differences in xenobiotic metabolism between experimental animals and humans. Schneider K, Griem P, Hassauer M, Schuhmacher-Wolz U, Naunyn-Schmiedebergs Archives of Pharmacology 2002 365 637
57. Griem P, Hassauer M, Kalberlah F, Oltmanns J, Scheibner J, Scheibner K, et al. Quantitative differences in xenobiotic metabolism between experimental animals and humans Dortmund: Federal Institute for Occupational Safety and Health (BAuA) Project F1656. 2002 http://www.baua.de/SharedDocs/Downloads/en/ Publications/Research-reports/2002/Fb963.pdf;jsessionid= 09152A06A7192DC35553DFA449219B8F.1-cid380?-blob=publicationFile, last accessed23/04/2013
58. Uncertainty factors for chemical risk assessment: interspecies differences in the in vivo pharmacokinetics and metabolism of human CYP1A2 substrates. Walton K, Dorne JL, Renwick AG, Food and Chem Toxicol 2001 39 667 680 10.1016/S0278-6915(01)00006-0 (Pubitemid 32523999)
59. Uncertainty factors for chemical risk assessment: interspecies differences in glucuronidation. Walton K, Dorne JL, Renwick AG, Food and Chem Toxicol 2001 39 1175 1190 10.1016/S0278-6915(01)00088-6 (Pubitemid 33030229)
60. Species-specific uncertainty factors for compounds eliminated principally by renal excretion in humans. Walton K, Dorne JLCM, Renwick AG, Food and Chem Toxicol 2004 42 261 274 10.1016/j.fct.2003.09.001 (Pubitemid 37510250)
61. A consistent approach for the application of pharmacokinetic modeling in cancer and noncancer risk assessment. Clewell HJ, Andersen ME, Barton HA, Environ Heal Perspect 2002 110 85 93 (Pubitemid 34110706)
62. Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. Freireich EJ, Gehan EA, Rall DP, Schmidt LH, Skipper HE, Cancer Chemother Rep 1966 50 219 244 4957125
63. Quantitative relationships between toxic doses of antitumor chemotherapeutic agents in animals and man. Homan ER, Cancer Chemother Rep Part 3 1972 3 13 19
64. Toxicity of pesticides to man: risks from present levels. Hayes WJJ, Proceedings of the Royal Society of London Series B, Containing Papers of a Biological Character 1967 167 101 127 10.1098/rspb.1967.0016
65. Problems in extrapolating toxicity data for laboratory-animals to Man. Dixon RL, Environ Heal Perspect 1976 13 43 50
66. Extrapolation of experimental data from animals to man. Krasovskii GN, Environ Heal Perspect 1976 13 51 58
67. Interspecies extrapolation in safety evaluation of human medicines in the Netherlands (1990-1992): practical considerations. Petersvolleberg GWM, Dewaal EJ, Vanderlaan JW, Regul Toxicol Pharmacol 1994 20 248 258 10.1006/rtph.1994. 1075 7724833
68. Allometric principles for interspecies extrapolation in toxicological risk assessment-empirical investigations. Schneider K, Oltmanns J, Hassauer M, Regul Toxicol Pharmacol 2004 39 334 347 10.1016/j.yrtph.2004.03.001 15135212 (Pubitemid 38596769)
69. Characterizing interspecies uncertainty using data from studies of anti-neoplastic agents in animals and humans. Price PS, Keenan RE, Swartout JC, Toxicol Appl Pharmacol 2008 233 64 70 10.1016/j.taap.2008.03.026 18514247
70. Analysis of the adequacy of safety factors. Sheehan DM, Gaylor DW, Teratology 1990 41 590 591
71. On reference dose (Rfd) and its underlying toxicity data-base. Dourson ML, Knauf LA, Swartout JC, Toxicol Ind Heal 1992 8 171 189
72. A toxicological basis to derive generic interspecies uncertainty factors for application in human and ecological risk assessment. Calabrese EJ, Baldwin LA, Human Ecol Risk Assess 1995 1 555 564 10.1080/10807039509380046
73. Data-base derived values for the interspecies extrapolation. Rennen M, Hakkert BC, Stevenson H, Bos PMJ, Comments Toxicol 2001 7 423 436
74. Deriving a data-based interspecies assessment factor using the NOAEL and the benchmark dose approach. Bokkers BGH, Slob W, Crit Rev Toxicol 2007 37 355 373 10.1080/10408440701249224 17612951 (Pubitemid 47035214)
75. Statistics Vs safety factors and scientific judgment in evaluation of safety for Man. Weil CS, Toxicol Appl Pharmacol 1972 21 454 10.1016/0041- 008X(72)90003-8 5047046
76. Human interindividual variability-a major source of uncertainty in assessing risks for noncancer health-effects. Hattis D, Silver K, Risk Analysis 1994 14 421 431 10.1111/j.1539-6924.1994.tb00260.x 7972952
77. Variability in susceptibility-How big, how often for what responses to what agents? Hattis D, Environ Toxicol Pharmacol 1996 2 135 145 10.1016/S1382-6689(96)00044-0 21781716 (Pubitemid 26389089)
78. Human variability and noncancer risk assessment-an analysis of the default uncertainty factor. Renwick AG, Lazarus NR, Regul Toxicol Pharmacol 1998 27 3 20 10.1006/rtph.1997.1195 9629592 (Pubitemid 28289017)
79. Human interindividual variability in parameters related to health risks. Hattis D, Banati P, Goble R, Burmaster DE, Risk Analysis 1999 19 711 726 10765432 (Pubitemid 29493864)
80. Human variability in xenobiotic metabolism and pathway-related uncertainty factors for chemical risk assessment: a review. Dorne JLCM, Walton K, Renwick AG, Food Chem Toxicol 2005 43 203 216 10.1016/j.fct.2004.05.011 15621332 (Pubitemid 40037938)
81. Empirically observed distributions of pharmacokinetic and pharmacodynamic variability in humans-implications for the derivation of single point component uncertainty factors providing equivalent protection as existing RfDs. Hattis D, Lynch MK, Toxicokinetics in risk assessment USA: Informa Healthcare, Lipscomb JC, Ohanian ED, 1999 69 93
82. Hattis D, Banati P, Goble R, Distributions of individual susceptibility among humans for toxic effects-How much protection does the traditional tenfold factor provide for what fraction of which kinds of chemicals and effects? New York: New York Academy of Sciences 1999
83. Review and evaluation of the potential impact of age- and gender-specific pharmacokinetic differences on tissue dosimetry. Clewell HJ, Teeguarden JG, McDonald T, Srangapani R, Lawrence G, Covington T, Gentry R, Shipp A, Crit Rev Toxicol 2002 32 329 389 10.1080/20024091064264 12389868 (Pubitemid 35191357)
84. Uncertainty factors and interindividual variation. Calabrese EJ, Regul Toxicol Pharmacol 1985 5 190 196 10.1016/0273-2300(85)90032-7 4023289 (Pubitemid 15060594)
85. The influence of genetic polymorphisms on population variability in Six xenobiotic-metabolizing enzymes. Ginsberg G, Smolenski S, Neafsey P, Hattis D, Walker K, Guyton KZ, Johns DO, Sonawane B, J Toxicol Environ Health-Part B-Critical Rev 2009 12 307 333 10.1080/10937400903158318
86. Genetic polymorphism in metabolism and host defense enzymes: implications for human health risk assessment. Ginsberg G, Guyton K, Johns D, Schimek J, Angle K, Sonawane B, Crit Rev Toxicol 2010 40 575 619 10.3109/10408441003742895 20662711
87. Do uncertainty factors take into account toxicokinetic interactions?: conclusions and recommendations from the sixth framework project NOMIRACLE. Dorne JL, Papadopoulos A, Toxicol Lett 2008 180 90 Supplement
88. An approach for the quantitative consideration of genetic polymorphism data in chemical risk assessment: examples with warfarin and parathion. Gentry PR, Hack CE, Haber L, Maier A, Clewell HJ, Toxicol Sci 2002 70 120 139 10.1093/toxsci/70.1.120 12388841 (Pubitemid 35331797)
89. Genetic polymorphisms in assessing interindividual variability in delivered dose. Haber LT, Maier A, Gentry PR, Clewell HJ, Dourson ML, Regul Toxicol Pharmacol 2002 35 177 197 10.1006/rtph.2001.1517 12052003 (Pubitemid 34664919)
90. Database for physiologically based pharmacokinetic (PBPK) modeling: physiological data for healthy and health-impaired elderly. Thompson CM, Johns DO, Sonawane B, Barton HA, Hattis D, Tardif R, Krishnan K, J Toxicol Environ Health-Part B-Critical Rev 2009 12 1 24 10.1080/10937400802545060
91. Pharmacokinetic and pharmacodynamic factors that can affect sensitivity to neurotoxic sequelae in elderly individuals. Ginsberg G, Hattis D, Russ A, Sonawane B, Environ Heal Perspect 2005 113 1243 1249 10.1289/ehp.7568 (Pubitemid 41387668)
92. Relevance of the 10X uncertainty factor to the risk assessment of drugs used by children and geriatrics. Skowronski GA, Abdel-Rahman MS, Human Ecol Risk Assess 2001 7 139 152 10.1080/20018091094259
93. Physiologically based pharmacokinetic (PBPK) modeling of caffeine and theophylline in neonates and adults: implications for assessing children's risks from environmental agents. Ginsberg G, Hattis D, Russ A, Sonawane B, J Toxicol Environ Health-Part A-Current Issues 2004 67 297 329 10.1080/15287390490273550 (Pubitemid 38200033)
94. Differences in pharmacokinetics between children and adults-II. Children's Variability in drug elimination half-lives and in some parameters needed for physiologically-based pharmacokinetic modeling. Hattis D, Ginsberg G, Sonawane B, Smolenski S, Russ A, Kozlak M, Goble R, Risk Analysis 2003 23 117 142 10.1111/1539-6924.00295 12635728 (Pubitemid 36255427)
95. Children's Health, susceptibility, and regulatory approaches to reducing risks from chemical carcinogens. Charnley G, Putzrath RM, Environ Heal Perspect 2001 109 187 192 10.1289/ehp.01109187 (Pubitemid 32280024)
96. National Research Council, Pesticides in the diets of infants and children Washington DC: National Academy Press Committee on improving risk analysis approaches used by the U.S.EPA. 1993
97. Differential sensitivity of children and adults to chemical toxicity-I. Biological basis. Scheuplein R, Charnley G, Dourson M, Regul Toxicol Pharmacol 2002 35 429 447 10.1006/rtph.2002.1558 12202057 (Pubitemid 35026242)
98. Pediatric susceptibility to 18 industrial chemicals: a comparative analysis of newborn with young animals. Hasegawa R, Hirata-Koizumi M, Dourson M, Parker A, Hirose A, Nakai S, Kamata E, Ema M, Regul Toxicol Pharmacol 2007 47 296 307 10.1016/j.yrtph.2006.10.003 17157422 (Pubitemid 46400239)
99. The relative tolerance of children and adults to anticancer drugs. Glaubiger DL, Vonhoff DD, Holcenberg JS, Kamen B, Pratt C, Ungerleider RS, Front Radiat Ther Oncol 1982 16 42 49
100. Differential sensitivity of children and adults to chemical toxicity-II. Risk and regulation. Dourson M, Charnley G, Scheuplein R, Regul Toxicol Pharmacol 2002 35 448 467 10.1006/rtph.2002.1559 12202058 (Pubitemid 35026243)
101. Drug disposition and action in infants and children. Rane A, Pediatric pharmacology-therapeutic principles in practice Philadelphia: W. B. Saunders Company, Yaffe SJ, Aranda JV, 1992 10 21
102. Assessing the default assumption that children are always at risk. Calabrese EJ, Human Ecol Risk Assess 2001 7 37 59 10.1080/20018091094204 (Pubitemid 33817302)
103. A probabilistic framework for the reference dose (probabilistic RfD). Swartout JC, Price PS, Dourson ML, Carlson-Lynch HL, Keenan RE, Risk Analysis 1998 18 271 282 10.1111/j.1539-6924.1998.tb01294.x 9664723 (Pubitemid 28300034)
104. Uncertainty in toxicological risk assessment for non-carcinogenic health effects. Kalberlah F, Schneider K, Schuhmacher-Wolz U, Regul Toxicol Pharmacol 2003 37 92 104 10.1016/S0273-2300(02)00032-6 12662913 (Pubitemid 36349341)
105. Application of quantitative information on the uncertainty in the RfD to noncarcinogenic risk assessments. Carlson-Lynch H, Price PS, Swartout JC, Dourson ML, Keenan RE, Human Ecol Risk Assess 1999 5 527 546
106. Schneider K, Hassauer M, Oltmanns J, Schuhmacher-Wolz U, Elmshauser E, Mosbach-Schulz O, Uncertainty analysis in Bundesanstalt für Arbeitsschutz und Arbeitsmedizin.: Workplace Effect Assessment Dortmund 2005
107. Noncancer risk assessment: a probabilistic alternative to current practice. Baird SJS, Cohen JT, Graham JD, Shlyakhter AI, Evans JS, Human Ecol Risk Assess 1996 2 79 102 10.1080/10807039.1996.10387463
108. A probabilistic approach for deriving acceptable human intake limits and human health risks from toxicological studies: general framework. Slob W, Pieters M, Risk Analysis 1998 18 787 798 10.1111/j.1539-6924.1998.tb01121.x 9972582
109. Percentiles of the product of uncertainty factors for establishing probabilistic reference doses. Gaylor DW, Kodell RL, Risk Analysis 2000 20 245 250 10.1111/0272-4332.202023 10859783 (Pubitemid 30354443)
110. Proposal of new uncertainty factor application to derive tolerable daily intake. Hasegawa R, Hirata-Koizumi M, Dourson M, Parker A, Sweeney LM, Nishikawa A, Yoshida M, Ono A, Hirose A, Regul Toxicol Pharmacol 2010 58 237 242 10.1016/j.yrtph.2010.06.006 20561553
111. Conundrums with uncertainty factors. Cooke R, Risk Analysis 2010 30 330 339 10.1111/j.1539-6924.2009.01336.x 20030767